表調(diào)節(jié)蛋白過表達與腎透明細胞癌患者預(yù)后的相關(guān)性及機制
Correlation and mechanism of EREG overexpression and prognosis of patients with renal clear cell carcinoma
ZHAO Jinguo1 ,ZHANG Bin2 ,JI Yaoxuan2,YU Lei1
(1.Department of Urology,Xijing Hospital,2.Department of Aviation Physiology,Department of Aerospace
Medicine,Air Force Medical University,Xi'an 710032,China)
ABSTRACT:ObjectiveTo explore therole and mechanism of epiregulin (EREG)in clearcell renal cellcarcinoma (ccRCC),andto find biomarkers and therapeutic targets for ccRCC.MethodsBased on the data from The Cancer Genome Atlas(TCGA)and Genotype-Tissue Expression(GTEx)databases,the corelation between the expression level of EREG in ccRCCtissues and theclinicalstaging and survival of ccRCC patients was analyzed.The samplesof 6ccRCCcases treated in the SecondAfilited Hospitalof theAirForce Medical Universitywerecollected.Theexpressionof EREGwas confirmed with immunohistochemistryandquantitativereal-time polymerase chain reaction(q-PCR).Theeffectsof EREG overexpressonon theproliferation,cellcycle and apoptosisof ACHN celswere verified with CCK-8and flow cytometry. Finall,the expresions of EREG,epidermal growth factor receptor(EGFR)and the downstream pathway proteins were detected with Western blotting.ResultsBased on the databases,it was found that theexpressonofEREG inccRCC samples was higherthanthatinadjacenttissues,andthere wasapositivecorelationwithteclinicalstage.Survivalanalysis showed that highexpresion of EREG was arisk factor affecting the prognosis.The resultsof immunohistochemical staining and qPCR revealed that EREG was highly expressed in ccRCC. Flow cytometry showed that EREG overexpresson promoted the proliferationofCHNcels,enanced cellcycle,and inhibited apoptosis.Inaddition,WesternblotingsuggestedthatEREG promoted the expressions of EREG,EGFR and the downstream proteins.ConclusionThe expression of EREG is sociated withthe prognosis of ccRCCpatients.In vitrocellexperiments have shown thatitcan promote the proliferationof ccRCCcels andinhibit theirapoptosis,thereby leading totheprogresionofccRCC.Itcanserve asapotentialbiomarkerforprognosis prediction and a drug development target for ccRCC patients.
KEY WORDS:clear cel renal cellcarcinoma; epiregulin; prognostic prediction; biomarker;proliferation;apoptosis
摘要:目的探索表調(diào)節(jié)蛋白(EREG)在腎透明細胞癌(ccRCC)中的作用及其機制,為ccRCC 尋找生物標志物及治療靶點。(剩余12993字)
-
-
- 現(xiàn)代泌尿外科雜志
- 2025年05期
- GnRH激動劑還是拮抗劑?前列...
- 激光在膀胱腫瘤治療中應(yīng)用的現(xiàn)狀...
- 1歲以下嬰兒原發(fā)性梗阻性巨輸尿...
- 微通道與超微通道經(jīng)皮腎鏡取石術(shù)...
- 肌電生物反饋輔助下的贊式盆底優(yōu)...
- 陰部神經(jīng)調(diào)控術(shù)治療女性陰部神經(jīng)...
- 腸道菌群與膀胱癌因果關(guān)系的孟德...
- 表調(diào)節(jié)蛋白過表達與腎透明細胞癌...
- 基于2005一2018年NHA...
- 孟德爾隨機化法分析腸道菌群、血...
- 腎移植術(shù)后患者發(fā)生尿路上皮癌中...
- 植人式神經(jīng)肌肉電刺激系統(tǒng)對雌性...
- 基于全外顯子組測序技術(shù)的前列腺...
- 新興技術(shù)及理論在泌尿系統(tǒng)腫瘤“...
- 重復(fù)腎上腎積水、輸尿管末端膨出...
- 腎髓質(zhì)癌1例報告...
- 機器人輔助腹腔鏡同期雙側(cè)腎部分...